NASDAQ | ETF
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| MORF | Morphic Holding Inc | Healthcare | Biotechnology | 1000.00% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 7.77% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 7.72% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 7.63% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 6.28% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 4.57% |
| IQV | IQVIA Holdings Inc | Healthcare | Diagnostics & Research | 3.14% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 2.86% |
| MTD | Mettler-Toledo International Inc | Healthcare | Diagnostics & Research | 2.83% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 2.63% |
| WAT | Waters Corporation | Healthcare | Diagnostics & Research | 2.41% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 2.20% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 2.16% |
| BNTX | BioNTech SE | Healthcare | Biotechnology | 2.06% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 1.65% |
| 0ONC | BEIGENE ADS REPRESENTING LTD | 1.63% | ||
| INCY | Incyte Corporation | Healthcare | Biotechnology | 1.55% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 1.51% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 1.49% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.43% |